Certain factors such as tumor size and specific histopathological and molecular features like TP53abn and L1CAM positivity, along with tumor subtypes such as clear cell, serous, undifferentiated, mixed (>10 %), and carcinosarcomas, are linked to a poorer prognosis and an increased risk of relapse [3]. This evidence concerns the gene L1CAM and carcinosarcoma.